Enovix Corporation Q1 2026 Financial Results: Key Highlights for Investors
Enovix Corporation has released its unaudited financial results for the first quarter ended April 5, 2026. The results were filed with the U.S. Securities and Exchange Commission on Form 10-Q. Below, we break down the key figures and important developments that investors should closely monitor.
Financial Performance Overview
- Revenue: The company reported total revenue for Q1 2026. While the specific revenue number does not appear explicitly in the extract, the gross profit for the quarter was \$261,000. This signifies that revenues, while present, remain at an early commercial stage.
- Net Loss: Enovix posted a net loss of \$38.3 million for Q1 2026, compared to a net loss of \$23.5 million for the comparative quarter, highlighting a significant increase in losses.
- Operating Loss: The operating loss for Q1 2026 was \$42.6 million.
- Comprehensive Loss: The company’s comprehensive loss, which includes other items beyond the net loss, was \$38.99 million.
- Earnings Per Share (EPS): The basic and diluted loss per share was \$0.18 for Q1 2026, compared to \$0.12 for Q1 2025. Note: Prior period share and per-share amounts were retroactively adjusted for a warrant dividend issued in July 2025.
Balance Sheet Strength
- Total Assets: Enovix reported \$833.9 million in total assets as of April 5, 2026, down from \$879.0 million as of December 28, 2025. This decrease is primarily due to the ongoing operating losses.
- Cash & Cash Equivalents: The company had \$106.0 million in cash and cash equivalents at quarter-end.
- Short-term Investments: \$440.0 million as of April 5, 2026.
- Long-term Investments: \$52.1 million.
- Property, Plant, and Equipment (Net): \$165.0 million.
- Total Equity: \$242.7 million including a non-controlling interest of \$2.1 million.
Shareholder Metrics & Capital Structure
- Shares Outstanding: There were 217,698,339 shares of common stock outstanding as of April 5, 2026.
- Equity Movements: During the quarter, 4,730 shares were issued upon stock option exercises, and 1,137,371 RSUs vested (net of shares withheld for taxes).
- Stockholders’ Equity: The company’s stockholders’ equity decreased to \$242.7 million, reflecting ongoing losses.
Forward-Looking Statements & Risks
- Growth Prospects: The company continues to pursue commercialization of its advanced battery technology, with a focus on scaling manufacturing and responding to customer demand.
- Risks: Management highlighted risks related to the company’s ability to execute on operational improvements, hire and retain talent, and maintain supply chain resilience. Furthermore, the company is not profitable and is dependent on its cash reserves and investments to fund operations.
Key Shareholder Considerations & Potential Price-Sensitive Information
- Significant Losses: The sharp increase in net loss quarter-over-quarter underscores ongoing high burn rates, which could be a concern for investors expecting near-term profitability.
- Cash Position: While the company has a substantial cash and investment balance, the current rate of loss suggests continued monitoring of cash runway is warranted.
- Warrant Dividend: There was a retroactive adjustment to shares and EPS figures associated with a warrant dividend issued in July 2025. This could impact share dilution calculations and investor models.
- No Indication of Default or Going Concern: The company does not report defaults on senior securities or other going concern warnings, but the sustained losses may remain a risk factor.
Conclusion
Enovix Corporation continues its transition from development-stage to commercial-stage operations. The company’s strong cash and investment balances provide a runway for continued R&D and scale-up, but the increase in quarterly losses and lack of material revenue growth remain key risk factors. Investors should closely monitor operational milestones, strategic partnerships, and any updates regarding commercialization progress—these could be major catalysts for future share price movement.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Readers should review the full SEC filing and consult with a financial advisor before making investment decisions. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
